The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
New insights into IL-12-mediated tumor suppression
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
Interleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced Macrophages
Hsieh, C.-S., Macatonia, S. E., Tripp, C. S., Wolf, S. F., O'Garra, A., & Murphy, K. M. (1993) · Science · doi:10.1126/science.8097338 · Cited by 3,134
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., & Vignali, D. A. A. (2007) · Nature · doi:10.1038/nature06306 · Cited by 2,066
Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., & Trinchieri, G. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.827 · Cited by 1,953
Manetti, R., Parronchi, P., Giudizi, M. G., Piccinni, M. P., Maggi, E., Trinchieri, G., & Romagnani, S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.1199 · Cited by 1,665
Pflanz, S., Timans, J. C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., Hibbert, L., Churakova, T., Travis, M., Vaisberg, E., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00324-2 · Cited by 1,462
D'Andrea, A., Aste-Amezaga, M., Valiante, N. M., Ma, X., Kubin, M., & Trinchieri, G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.3.1041 · Cited by 1,385
Adenoma–linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Grivennikov, S. I., Wang, K., Mucida, D., Stewart, C. A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.-Y., Österreicher, C. H., Hung, K. E., et al. (2012) · Nature · doi:10.1038/nature11465 · Cited by 1,327
IL-12 family cytokines: immunological playmakers
Vignali, D. A. A., & Kuchroo, V. K. (2012) · Nature Immunology · doi:10.1038/ni.2366 · Cited by 1,297
Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., & Gately, M. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.4.1223 · Cited by 1,197
T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells
Afkarian, M., Sedy, J. R., Yang, J., Jacobson, N. G., Cereb, N., Yang, S. Y., Murphy, T. L., & Murphy, K. M. (2002) · Nature Immunology · doi:10.1038/ni794 · Cited by 1,037
IL-23 promotes tumour incidence and growth
Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., & Oft, M. (2006) · Nature · doi:10.1038/nature04808 · Cited by 1,018
Szabo, S. J., Dighe, A. S., Gubler, U., & Murphy, K. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.817 · Cited by 1,005
Chan, S. H., Perussia, B., Gupta, J. W., Kobayashi, M., Pospísil, M., Young, H. A., Wolf, S. F., Young, D., Clark, S. C., & Trinchieri, G. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.4.869 · Cited by 961
Leonard, J. P., Sherman, M. L., Fisher, G. L., Buchanan, L. J., Larsen, G., Atkins, M. B., Sosman, J. A., Dutcher, J. P., Vogelzang, N. J., & Ryan, J. L. (1997) · PubMed · Cited by 820
Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma
Daud, A. I., DeConti, R. C., Andrews, S., Urbas, P., Riker, A. I., Sondak, V. K., Munster, P. N., Sullivan, D. M., Ugen, K. E., Messina, J. L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6794 · Cited by 701
Cytokines in Cancer Immunotherapy
Lee, S., & Margolin, K. (2011) · Cancers · doi:10.3390/cancers3043856 · Cited by 693
A functional interleukin 12 receptor complex is composed of two β-type cytokine receptor subunits
Presky, D. H., Yang, H., Minetti, L. J., Chua, A. O., Nabavi, N., Wu, C.-Y., Gately, M. K., & Gubler, U. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14002 · Cited by 689
Interleukin-12 in anti-tumor immunity and immunotherapy
Colombo, M. P., & Trinchieri, G. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00032-6 · Cited by 685
Pegram, H. J., Lee, J. C., Hayman, E. G., Imperato, G. H., Tedder, T. F., Sadelain, M., & Brentjens, R. J. (2012) · Blood · doi:10.1182/blood-2011-12-400044 · Cited by 678
The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells.
Ma, X., Chow, J. M., Gri, G., Carra, G., Gerosa, F., Wolf, S. F., Dzialo, R., & Trinchieri, G. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.147 · Cited by 648
Micallef, M. J., Ohtsuki, T., Kohno, K., Tanabe, F., Ushio, S., Namba, M., Tanimoto, T., Torigoe, K., Fujii, M., Ikeda, M., et al. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260736 · Cited by 597
Atkins, M. B., Robertson, M. J., Gordon, M. S., Lotze, M. T., DeCoste, M., DuBois, J. S., Ritz, J., Sandler, A. B., Edington, H. D. J., Garzone, P. D., et al. (1997) · PubMed · Cited by 583
Gubler, U., Chua, A. O., Schoenhaut, D. S., Dwyer, C. M., McComas, W., Motyka, R., Nabavi, N., Wolitzky, A. G., Quinn, P. M., & Familletti, P. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4143 · Cited by 576
Schulz, O., Edwards, A. D., Schito, M., Aliberti, J., Manickasingham, S., Sher, A., & Reis e Sousa, C. (2000) · Immunity · doi:10.1016/s1074-7613(00)00045-5 · Cited by 561
Djuretic, I. M., Levanon, D., Negreanu, V., Groner, Y., Rao, A., & Ansel, K. M. (2007) · Nature Immunology · doi:10.1038/ni1424 · Cited by 532
Cloning and expression of murine IL-12
Schoenhaut, D. S., Chua, A. O., Wolitzky, A. G., Quinn, P. M., Dwyer, C. M., McComas, W., Familletti, P. C., Gately, M. K., & Gubler, U. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.11.3433 · Cited by 470
Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10
Sgadari, C., Angiolillo, A., & Tosato, G. (1996) · Blood · doi:10.1182/blood.v87.9.3877.bloodjournal8793877 · Cited by 469
Gately, M. K., Desai, B. B., Wolitzky, A. G., et al. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.3.874 · Cited by 461
Interleukin-18: A Novel Cytokine That Augments Both Innate and Acquired Immunity
(1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60389-2 · Cited by 450
Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes.
Bacon, C. M., Petricoin, E. F., Ortaldo, J. R., Rees, R. C., Larner, A. C., Johnston, J. A., & O'Shea, J. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7307 · Cited by 449
Bacon, C. M., McVicar, D. W., Ortaldo, J. R., Rees, R. C., O'Shea, J. J., & Johnston, J. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.1.399 · Cited by 350
IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
Kerkar, S. P., Goldszmid, R. S., Muranski, P., Chinnasamy, D., Yu, Z., Reger, R. N., Leonardi, A. J., Morgan, R. A., Wang, E., Marincola, F. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58814 · Cited by 342
Parker, J. N., Gillespie, G. Y., Love, C. E., Randall, S., Whitley, R. J., & Markert, J. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040557897 · Cited by 332
Tahara, H., Zeh, H. J., Storkus, W. J., Pappo, I., Watkins, S. C., Gubler, U., Wolf, S. F., Robbins, P., & Lotze, M. T. (1994) · PubMed · Cited by 326
Perussia, B., Chan, S. H., D’Andrea, A., Tsuji, K., Santoli, D., Pospisil, M., Young, D., Wolf, S. F., & Trinchieri, G. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.11.3495 · Cited by 324
Sangro, B., Mazzolini, G., Ruiz, J., Herraiz, M., Quiroga, J., Herrero, I., Benito, A., Larrache, J., Pueyo, J., Subtil, J. C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.059 · Cited by 320
The Anti-Tumor Activity of IL-12: Mechanisms of Innate Immunity That Are Model and Dose Dependent
Smyth, M. J., Taniguchi, M., & Street, S. E. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2665 · Cited by 301
Zhang, L., Kerkar, S. P., Yu, Z., Zheng, Z., Yang, S., Restifo, N. P., Rosenberg, S. A., & Morgan, R. A. (2011) · Molecular Therapy · doi:10.1038/mt.2010.313 · Cited by 293
Gollob, J., Mier, J. W., Veenstra, K. G., McDermott, D. F., Clancy, D., Clancy, M., & Atkins, M. B. (2000) · PubMed · Cited by 285
Grohmann, U., Belladonna, M. L., Bianchi, R., Orabona, C., Ayroldi, E., Fioretti, M. C., & Puccetti, P. (1998) · Immunity · doi:10.1016/s1074-7613(00)80614-7 · Cited by 283
Rook, A. H., Wood, G. S., Yoo, E. K., Elenitsas, R., Kao, D. M. F., Sherman, M. L., Witmer, W. K., Rockwell, K. A., Shane, R. B., Lessin, S. R., et al. (1999) · Blood · doi:10.1182/blood.v94.3.902.415k23_902_908 · Cited by 277
Lucas, M. L., Heller, L., Coppola, D., & Heller, R. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0601 · Cited by 253
Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature
Halin, C., Rondini, S., Nilsson, F., Berndt, A., Kosmehl, H., Zardi, L., & Neri, D. (2002) · Nature Biotechnology · doi:10.1038/nbt0302-264 · Cited by 252
Nanni, P., Nicoletti, G., De Giovanni, C., Landuzzi, L., Di Carlo, E., Cavallo, F., Pupa, S. M., Rossi, I., Colombo, M. P., Ricci, C., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.9.1195 · Cited by 230
Managing toxicities of high-dose interleukin-2.
Schwartz, R. N., Stover, L. L., & Dutcher, J. P. (2002) · PubMed · Cited by 229
Eisenring, M., vom Berg, J., Kristiansen, G., Saller, E., & Becher, B. (2010) · Nature Immunology · doi:10.1038/ni.1947 · Cited by 221
Self-citationImmunotherapy of cancer by IL-12-based cytokine combinations
Weiss, J. M., Subleski, J. J., Wigginton, J. M., & Wiltrout, R. H. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.11.1705 · Cited by 221
Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection
vom Berg, J., Vrohlings, M., Haller, S., Haimovici, A., Kulig, P., Sledzinska, A., Weller, M., & Becher, B. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130678 · Cited by 213
Self-citationMeyaard, L., Hovenkamp, E., Otto, S. A., & Miedema, F. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.8.2776 · Cited by 207
Bramson, J. L., Hitt, M., Addison, C. L., Muller, W. J., Gauldie, J., & Graham, F. L. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.16-1995 · Cited by 188
Antiangiogenic and Antitumor Activities of IL-27
Shimizu, M., Shimamura, M., Owaki, T., Asakawa, M., Fujita, K., Kudo, M., Iwakura, Y., Takeda, Y., Luster, A. D., Mizuguchi, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7317 · Cited by 177
Cavallo, F., Giovarelli, M., Forni, G., Signorelli, P., Musiani, P., Modesti, A., Brunda, M. J., & Colombo, M. P. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.14.1049 · Cited by 171
Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma.
Bajetta, E., Vecchio, M. D., Mortarini, R., Nadeau, R., Rakhit, A. K., Rimassa, L., Fowst, C., Borri, A., Anichini, A., & Parmiani, G. (1998) · PubMed · Cited by 163
IL-12 receptor β1 deficiency alters in vivo T follicular helper cell response in humans
Schmitt, N., Bustamante, J., Bourdery, L., Bentebibel, S. E., Boisson-Dupuis, S., Hamlin, F., Tran, M. V., Blankenship, D., Pascual, V., Savino, D. A., et al. (2013) · Blood · doi:10.1182/blood-2012-08-448902 · Cited by 163
Tumor-Derived IL-35 Promotes Tumor Growth by Enhancing Myeloid Cell Accumulation and Angiogenesis
Wang, Z., Liu, J.-Q., Liu, Z., Shen, R. Z., Zhang, G., Xu, J., Basu, S., Feng, Y., & Bai, X. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202535 · Cited by 163
IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis
Teng, M. W. L., Andrews, D. M., McLaughlin, N. M., von Scheidt, B., Ngiow, S. F., Möller, A., Hill, G. R., Iwakura, Y., Oft, M., & Smyth, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003251107 · Cited by 161
Salcedo, R., Stauffer, J. K., Lincoln, E., Back, T. C., Hixon, J. A., Hahn, C., Shafer-Weaver, K., Malyguine, A., Kastelein, R., & Wigginton, J. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.12.7170 · Cited by 161
The immunocytokine NHS-IL12 as a potential cancer therapeutic
Fallon, J., Tighe, R., Kradjian, G., Guzman, W., Bernhardt, A., Neuteboom, B., Lan, Y., Sabzevari, H., Schlom, J., & Greiner, J. W. (2014) · Oncotarget · doi:10.18632/oncotarget.1853 · Cited by 160
Heinzerling, L., Burg, G., Dummer, R., Maier, T., Oberholzer, P. A., Schultz, J. G., Elzaouk, L., Pavlovic, J., & Moelling, K. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.35 · Cited by 154
Kuwajima, S., Sato, T., Ishida, K., Tada, H., Tezuka, H., & Ohteki, T. (2006) · Nature Immunology · doi:10.1038/ni1348 · Cited by 152
Seo, S. H., Kim, K. S., Park, S. H., Suh, Y. S., Kim, S. J., Jeun, S.-S., & Sung, Y. C. (2011) · Gene Therapy · doi:10.1038/gt.2010.170 · Cited by 148
Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12
Kanegane, C., Sgadari, C., Kanegane, H., Teruya‐Feldstein, J., Yao, L., Gupta, G. D., Farber, J. M., Liao, F., Liu, L., & Tosato, G. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.3.384 · Cited by 148
Ansell, S. M., Witzig, T. E., Kurtin, P. J., et al. (2002) · Blood · doi:10.1182/blood.v99.1.67 · Cited by 148
Pützer, B. M., Hitt, M., Muller, W. J., Emtage, P. C. R., Gauldie, J., & Graham, F. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10889 · Cited by 146
Egilmez, N. K., Jong, Y. S., Sabel, M. S., Jacob, J. S., Mathiowitz, E., & Bankert, R. B. (2000) · PubMed · Cited by 143
Effect of interleukin 12 on tumor induction by 3-methylcholanthrene.
Noguchi, Y., Jungbluth, A., Richards, E. C., & Old, L. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11798 · Cited by 143
Oniki, S., Nagai, H., Horikawa, T., Furukawa, J., Belladonna, M. L., Yoshimoto, T., Hara, I., & Nishigori, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4087 · Cited by 141
Zou, J., Presky, D. H., Wu, C. Y., & Gubler, U. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.6073 · Cited by 139
IL-12 regulates VEGF and MMPs in a murine breast cancer model
Dias, S., Boyd, R., & Balkwill, F. R. (1998) · International Journal of Cancer · Cited by 137
Aste-Amezaga, M., D'Andrea, A., Kubin, M., & Trinchieri, G. (1994) · Cellular Immunology · doi:10.1006/cimm.1994.1192 · Cited by 136
Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo.
Rogge, L., Papi, A. A., Presky, D. H., Biffi, M., Minetti, L. J., Miotto, D., Agostini, C., Semenzato, G., Fabbri, L. M., & Sinigaglia, F. (1999) · PubMed · doi:10.4049/jimmunol.162.7.3924 · Cited by 135
Antiproliferative Activity of IL-27 on Melanoma
Yoshimoto, T., Morishima, N., Mizoguchi, I., Shimizu, M., Nagai, H., Oniki, S., Oka, M., Nishigori, C., & Mizuguchi, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6527 · Cited by 129
Modulation of perforin and granzyme messenger RNA expression in human natural killer cells.
Salcedo, T. W., Azzoni, L., Wolf, S. F., & Perussia, B. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2511 · Cited by 124
Martinotti, A., Stoppacciaro, A., Vagliani, M., et al. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250124 · Cited by 122
Expression and Function of IL-12 and IL-18 Receptors on Human Tonsillar B Cells
Airoldi, I., Gri, G., Marshall, J. D., Corcione, A., Facchetti, P., Guglielmino, R., Trinchieri, G., & Pistoia, V. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.6880 · Cited by 121
Grohmann, U., Bianchi, R., Ayroldi, E., Belladonna, M. L., Surace, D., Fioretti, M. C., & Puccetti, P. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3593 · Cited by 118
Motzer, R. J., Rakhit, A. K., Thompson, J. A., et al. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/107999001750169934 · Cited by 118
Portielje, J. E. A., Kruit, W. H. J., Schüler, M., Beck, J., Lamers, C. H., Stoter, G., Huber, C. H., de Boer-Dennert, M. M., Rakhit, A. K., Bolhuis, R. L. H., et al. (1999) · PubMed · Cited by 118
Antibodies to the IL-12 Receptor β2 Chain Mark Human Th1 But Not Th2 Cells In Vitro and In Vivo
Rogge, L., Papi, A. A., Presky, D. H., Biffi, M., Minetti, L. J., Miotto, D., Agostini, C., Semenzato, G., Fabbri, L. M., & Sinigaglia, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3926 · Cited by 118
Positive Regulatory Role of IL-12 in Macrophages and Modulation by IFN-γ
Grohmann, U., Belladonna, M. L., Vacca, C., Bianchi, R., Fallarino, F., Orabona, C., Fioretti, M. C., & Puccetti, P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.221 · Cited by 117
Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy
Airoldi, I. (2005) · Blood · doi:10.1182/blood-2005-05-2034 · Cited by 117
Hill, H. C., Conway, T. F., Sabel, M. S., Jong, Y. S., Mathiowitz, E., Bankert, R. B., & Egilmez, N. K. (2002) · PubMed · Cited by 117
Bekaii‐Saab, T., Roda, J. M., Guenterberg, K. D., Ramaswamy, B., Young, D. C., Ferketich, A. K., Lamb, T., Grever, M. R., Shapiro, C. L., & Carson, W. E. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0820 · Cited by 113
Intratumoral injection of IL-12 plasmid DNA – results of a phase I/IB clinical trial
Mahvi, D. M., Henry, M. B., Albertini, M. R., Weber, S. M., Meredith, K. L., Schalch, H., Rakhmilevich, A. L., Hank, J. A., & Sondel, P. M. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701064 · Cited by 112
Rudman, S. M., Jameson, M. B., McKeage, M. J., Savage, P. M., Jodrell, D. I., Harries, M., Acton, G. D., Erlandsson, F., & Spicer, J. F. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2490 · Cited by 109
Anwer, K., Barnes, M. N., Fewell, J. G., Lewis, D. H., & Alvarez, R. D. (2009) · Gene Therapy · doi:10.1038/gt.2009.159 · Cited by 108
Younes, A., Pro, B., Robertson, M. J., Flinn, I. W., Romaguera, J. E., Hagemeister, F. B., Dang, N. H., Fiumara, P. F., Loyer, E. M., Cabanillas, F., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0540 · Cited by 106
Emtage, P. C. R., Wan, Y., Hitt, M., Graham, F. L., Muller, W. J., Zlotnik, A., & Gauldie, J. (1999) · Human Gene Therapy · doi:10.1089/10430349950018463 · Cited by 105
Hu, J., Yuan, X., Belladonna, M. L., Ong, J. M., Wachsmann‐Hogiu, S., Farkas, D. L., Black, K. L., & Yu, J. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3448 · Cited by 102
IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production
Jaime-Ramirez, A. C., Mundy-Bosse, B. L., Kondadasula, S., Jones, N. B., Roda, J. M., Mani, A., Parihar, R., Karpa, V., Papenfuss, T. L., LaPerle, K. M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000328 · Cited by 100
Hurteau, J. A., Blessing, J. A., Decesare, S. L., & Creasman, W. T. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6255 · Cited by 100
Portielje, J. E. A., Lamers, C. H. J., Kruit, W. H. J., Sparreboom, A., Bolhuis, R. L. H., Stoter, G., Huber, C., & Gratama, J. W. (2003) · PubMed · Cited by 97
Kaiga, T., Sato, M., Kaneda, H., Iwakura, Y., Takayama, T., & Tahara, H. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7571 · Cited by 97
Interleukin-27 Acts as Multifunctional Antitumor Agent in Multiple Myeloma
Cocco, C., Giuliani, N., Carlo, E. D., Ognio, E., Storti, P., Abeltino, M., Sorrentino, C., Ponzoni, M., Ribatti, D., & Airoldi, I. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0173 · Cited by 96
IL-27 in tumor immunity and immunotherapy
Murugaiyan, G., & Saha, B. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.12.002 · Cited by 95
van Herpen, C. M., Looman, M. W. G., Zonneveld, M. I., Scharenborg, N. M., de Wilde, P. C., van de Locht, L. T., Merkx, M. A. W., Adema, G. J., & de Mulder, P. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0304 · Cited by 92
Boggio, K., Carlo, E. D., Rovero, S., Cavallo, F., Quaglino, E., Lollini, P., Nanni, P., Nicoletti, G., Wolf, S., Musiani, P., et al. (2000) · PubMed · Cited by 91
Expression of Murine IL-12 Is Regulated by Translational Control of the p35 Subunit
Babik, J. M., Adams, E., Tone, Y., Fairchild, P. J., Tone, M., & Waldmann, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.4069 · Cited by 83
Alvarez, R. D., Sill, M. W., Davidson, S. A., Muller, C. Y., Bender, D., Debernardo, R., Behbakht, K., & Huh, W. K. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.03.571 · Cited by 81
Alatrash, G., Hutson, T. E., Moltó, L. M., Richmond, A. L., Nemec, C., Mekhail, T. M., Elson, P. J., Tannenbaum, C. S., Olencki, T. E., Finke, J. H., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.045 · Cited by 79
Mechanism of inhibition of LPS-induced IL-12p40 production by IL-10 and TGF-β in ANA-1 cells
Du, C., & Sriram, S. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.1.92 · Cited by 78
Meeran, S. M., Mantena, S. K., Meleth, S., Elmets, C. A., & Katiyar, S. K. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0003 · Cited by 73
Duvic, M., Sherman, M. L., Wood, G. S., et al. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.06.038 · Cited by 71
Chang, C.-J., Chen, Y.-H., Huang, K., Cheng, H.-W., Chan, S.-F., Tai, K., & Hwang, L. (2007) · Hepatology · doi:10.1002/hep.21560 · Cited by 69
Chowdhury, F. Z., Ramos, H. J., Davis, L. S., Forman, J., & Farrar, J. D. (2011) · Blood · doi:10.1182/blood-2011-05-357111 · Cited by 69
Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity
Palmer, K., Hitt, M., Emtage, P. C. R., Gyorffy, S., & Gauldie, J. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301386 · Cited by 68
Rakhmilevich, A. L., Janssen, K., Hao, Z., et al. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700176 · Cited by 68
Sabel, M. S., Skitzki, J. J., Stoolman, L. M., Egilmez, N. K., Mathiowitz, E., Bailey, N. A., Chang, W.-J., & Chang, A. E. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.03.022 · Cited by 68
Collapse of the Tumor Stroma is Triggered by IL-12 Induction of Fas
Kerkar, S. P., Leonardi, A. J., van Panhuys, N., Zhang, L., Yu, Z., Crompton, J. G., Pan, J. H., Palmer, D. C., Morgan, R. A., Rosenberg, S. A., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.58 · Cited by 67
Sorensen, E. W., Gerber, S. A., Frelinger, J. G., & Lord, E. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903210 · Cited by 63
Autocrine IL-12 Is Involved in Dendritic Cell Modulation Via CD40 Ligation
Bianchi, R., Grohmann, U., Vacca, C., Belladonna, M. L., Fioretti, M. C., & Puccetti, P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.5.2517 · Cited by 63
Zilocchi, C., Stoppacciaro, A., Chiodoni, C., Parenza, M., Terrazzini, N., & Colombo, M. P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.133 · Cited by 60
Procházková, J., Pokorná, K., & Holáň, V. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.07.032 · Cited by 59
IL-12 Regulates an Endothelial Cell-Lymphocyte Network: Effect on Metalloproteinase-9 Production
Mitola, S., Strasly, M., Prato, M., Ghia, P., & Bussolino, F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3725 · Cited by 58
Lacy, M. Q., Jacobus, S. J., Blood, E., Kay, N. E., Rajkumar, S. V., & Greipp, P. R. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.01.020 · Cited by 57
Lohr, F., Hu, K., Haroon, Z. A., Samulski, T. V., Huang, Q., Beaty, J. S., Dewhirst, M. W., & Li, C. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0114 · Cited by 54
Interleukin-27 Inhibits the Growth of Pediatric Acute Myeloid Leukemia in NOD/SCID/Il2rg−/− Mice
Zorzoli, A., Carlo, E. D., Cocco, C., Ognio, E., Ribatti, D., Ferretti, E., Dufour, C., Locatelli, F., Montagna, D., & Airoldi, I. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2432 · Cited by 54
Teng, M. W. L., von Scheidt, B., Duret, H., Towne, J. E., & Smyth, M. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3994 · Cited by 54
Passer, B. J., Cheema, T. A., Wu, S., Wu, C.-L., Rabkin, S. D., & Martuza, R. L. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.75 · Cited by 52
Okada, N., Iiyama, S., Okada, Y., Mizuguchi, H., Hayakawa, T., Nakagawa, S., Mayumi, T., Fujita, T., & Yamamoto, A. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700772 · Cited by 51
Triozzi, P. L., Allen, K. O., Carlisle, R. R., Craig, M. C., LoBuglio, A. F., & Conry, R. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2283 · Cited by 51
Regression of High-Grade Malignancy in Mice by Bleomycin and Interleukin-12 Electrochemogenetherapy
Torrero, M. N., Henk, W. G., & Li, S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1514 · Cited by 47
Malvicini, M., Rizzo, M., Alaniz, L. D., Piñero, F., García, M. G., Atorrasagasti, C., Aquino, J. B., Rozados, V. R., Scharovsky, O. G., Matar, P., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1861 · Cited by 45
Jahn, T., Zuther, M., Friedrichs, B., Heuser, C., Guhlke, S., Abken, H., & Hombach, A. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044482 · Cited by 43
Semliki Forest virus-mediated gene therapy of the RG2 rat glioma
Roche, F. P., Sheahan, B. J., O’Mara, S. M., & Atkins, G. J. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01110.x · Cited by 41
Liu, J., Xiang, Z., & Ma, X. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1184 · Cited by 41
Gerber, S. A., Moran, J. P., Frelinger, J. G., Frelinger, J. G., Fenton, B. M., & Lord, E. M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600907 · Cited by 38
Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-α in a model of metastatic breast cancer
Sabel, M. S., Su, G., Griffith, K. A., & Chang, A. E. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0570-3 · Cited by 38
Cao, L., Zeng, Q., Xu, C., Shi, S., Zhang, Z., & Sun, X. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300602j · Cited by 36
Teicher, B. A., Ara, G., Buxton, D., Leonard, J., & Schaub, R. G. (1997) · PubMed · Cited by 34
Sonabend, A. M., Velicu, S., Ulasov, I. V., Han, Y., Tyler, B., Brem, H., Matar, M. M., Fewell, J. G., Anwer, K., & Lesniak, M. S. (2008) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3282f24017 · Cited by 34
Malvicini, M., Ingolotti, M., Piccioni, F., García, M. G., Bayo, J., Atorrasagasti, C., Alaniz, L. D., Aquino, J. B., Espinoza, J. A., Gidekel, M., et al. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.03.007 · Cited by 33
Producer cells of interleukin-12
Trinchieri, G., Rengaraju, M., D’Andrea, A., Valiante, N. M., Kubin, M. Z., Aste-Amézaga, M., & Chehimi, J. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90173-i · Cited by 33
Shi, X., Cao, S., Mitsuhashi, M., Xiang, Z., & Ma, X. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4111 · Cited by 29
Rakhmilevich, A. L., Hooper, A. T., Hicklin, D. J., & Sondel, P. M. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.969.3.8 · Cited by 27
Lisiero, D. N., Soto, H., Liau, L. M., & Prins, R. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003317 · Cited by 25
Systemic interleukin 12 displays anti-tumour activity in the mouse central nervous system
Kishima, H., Shimizu, K., Miyao, Y., Mabuchi, E., Tamura, K., Tamura, M., Sasaki, M., & Hakakawa, T. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.513 · Cited by 24
Gene expression analysis in Interleukin‐12‐induced suppression of mouse mammary carcinoma
Shi, X., Liu, J., Xiang, Z., Mitsuhashi, M., Wu, R. S., & Ma, X. (2004) · International Journal of Cancer · doi:10.1002/ijc.20145 · Cited by 22
Preexisting antitumor immunity augments the antitumor effects of chemotherapy
Zhang, L., Feng, D., Yu, L. X., Tsung, K., & Norton, J. A. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1417-7 · Cited by 21
Cocco, C., Pistoia, V., & Airoldi, I. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.11.006 · Cited by 17
Zitvogel, L., & Lotze, M. T. (1995) · Research in Immunology · doi:10.1016/0923-2494(96)83041-0 · Cited by 17
Vetter, M., Hofer, M. J., Roth, E., Pircher, H., & Pagenstecher, A. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181a2afa0 · Cited by 13
Reay, J. C., Gambotto, A. A., & Robbins, P. D. (2011) · Cancer Gene Therapy · doi:10.1038/cgt.2011.78 · Cited by 12
Zagożdżon, R., Giermasz, A., Gołąb, J., Stokłosa, T., Jalili, A., & Jakóbisiak, M. (1999) · Cancer Letters · doi:10.1016/s0304-3835(99)00277-3 · Cited by 9
Cited by
Interleukins in cancer: from biology to therapy
Briukhovetska, D., Dörr, J., Endres, S., Libby, P., Dinarello, C. A., & Kobold, S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00363-z · Cited by 781
He, Y., Fu, L., Li, Y., Wang, W., Gong, M., Zhang, J., Dong, X., Huang, J., Wang, Q., Mackay, C. R., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.002 · Cited by 729
Saha, D., Martuza, R. L., & Rabkin, S. D. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.006 · Cited by 591
The Limitless Future of RNA Therapeutics
Damase, T. R., Sukhovershin, R., Boada, C., Taraballi, F., Pettigrew, R. I., & Cooke, J. P. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.628137 · Cited by 544
Localized Interleukin-12 for Cancer Immunotherapy
Nguyen, K. G., Vrabel, M. R., Mantooth, S. M., Hopkins, J. J., Wagner, E. S., Gabaldon, T. A., & Zaharoff, D. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.575597 · Cited by 431
Metadata
- Authors
- Tugues, S., Burkhard, S. H., Ohs, I., Vrohlings, M., Nussbaum, K., vom Berg, J., Kulig, P., & Becher, B.
- Venue
- Cell Death & Differentiation
- Published
- 2014-09-05
- Volume
- 22
- Issue
- 2
- Pages
- 237-246
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W2082554712
- Cited by
- 558
- References
- 146
- FWCI
- 8.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.